SII & Bharat Biotech confirm: No ban on vaccine export from India
Publish- January 06, 2021, 12:26 AM
UNB NEWS - UNB NEWS
Serum Institute of India and Bharat Biotech have jointly communicated their pledge towards a smooth roll out of Covid-19 vaccines to India and the world.
Adar Poonawala, Chief Executive Office of Serum Institute, and Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech, on Tuesday communicated their intention to develop, manufacture and supply the Covid-19 vaccines for India and globally.
Now that two Covid-19 vaccines have been issued EUA (emergency use authorization) in India, the focus is on manufacturing, supply and distribution, such that populations that need it the most receive high quality, safe and efficacious vaccines. "Both our companies are fully engaged in this activity and consider it our duty to the nation and the world at large to ensure a smooth rollout of vaccines," they said.